T Cell News and Research

Latest T Cell News and Research

Promising COVID-19 drug treatments identified with new screening strategies

As scientists across the world race to find a pharmacological cure for coronavirus disease (COVID-19), an international research group has analyzed more than 10 thousand different compounds and identified six potential candidates, publishing their results in the leading scientific journal Nature.

12 Apr 2020

Recovered South Korean COVID-19 patients test positive again

Following the reports from different countries of patients recovered from coronavirus disease (COVID-19) but testing positive again during the control diagnostic appraisal, South Korea's Centers for Disease Control and Prevention (CDC) documents a similar occurrence in 51 patients.

12 Apr 2020

Stuttering DNA controls development of mosquito embryos

All organisms have DNA, the genetic material that provides a blueprint for life. The long double-helix-shaped DNA molecules in the body's cells are first translated into RNA molecules and then translated into proteins that ensure the functioning of the cell and the entire organism.

12 Apr 2020

PARP inhibitor drugs can be structurally modified to better kill tumor cells

A prospective "PARP inhibitor" drug that has struggled to show effectiveness in clinical trials against cancers can be structurally modified to greatly increase its power to kill tumor cells, researchers from Penn Medicine report this week in Science.

12 Apr 2020

Researchers identify new risk gene for Parkinson's disease

Screening DNA of Parkinson's patients in the Christine Van Broeckhoven laboratory (VIB-UAntwerpen Center for Molecular Neurology) identified a new risk gene for Parkinson's disease. Mutations in ATP10B resulted in loss of ATP10B protein.

12 Apr 2020

UTSW researchers uncover shape of key protein involved in muscle contraction

Researchers at UT Southwestern Medical Center have uncovered the detailed shape of a key protein involved in muscle contraction. The report, published today in Neuron, may lead to improved understanding of muscle-weakening genetic conditions called congenital myasthenic syndromes.

12 Apr 2020

Where cancers spread can give specific insights on disease traits

Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.

12 Apr 2020

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

After a lightening round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells to block the life-threatening lung inflammation that accompanies severe cases of COVID-19.

11 Apr 2020

Researchers discover how sweet taste perception is fine-tuned in response to diets

Researchers at the University of Sydney have discovered the basic science of how sweet taste perception is fine-tuned in response to different diets.

10 Apr 2020

Recommendations for keeping cancer patients, providers safe during COVID-19 pandemic

The National Comprehensive Cancer Network--an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019.

10 Apr 2020

Study sheds light on how a group of novel organelle-based disorders affects cells

A pioneering study has shed new light on how a group of novel organelle-based disorders affect cells.

10 Apr 2020

Researchers identify COVID-19 drug lead treatments

An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.

9 Apr 2020

Microneedle patches for potential COVID-19 vaccines or therapeutics

The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.

9 Apr 2020

Weekly COVID-19 fatality predictions from leading epidemiologists

While many developed and developing countries are reeling under the impact of the SARS-CoV-2 virus, which causes COVID-19 disease, preventive and therapeutic measures alike need more accurate forecasts of fatal and non-fatal events to achieve preparedness and ensure an optimal outcome. Now scientists at Imperial College, London, have come up with a new weekly forecast of the number of deaths due to coronavirus and the likely number of cases reported in countries where the virus is actively spreading.

9 Apr 2020

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

9 Apr 2020

Researchers identify protein that plays critical role in cancer treatment-related heart damage

Many cancers can be successfully treated, but treatment itself often comes with risks as well. Cancer therapy that uses anthracyclines--a class of commonly used chemotherapy drugs--has been associated with heart damage that can eventually result in heart failure. It is thought to be the reason why heart disease is a leading cause of death in cancer survivors, immediately following cancer recurrence.

9 Apr 2020

T Cell News and Research

Latest T Cell News and Research

Promising COVID-19 drug treatments identified with new screening strategies

Recovered South Korean COVID-19 patients test positive again

Stuttering DNA controls development of mosquito embryos

PARP inhibitor drugs can be structurally modified to better kill tumor cells

Researchers identify new risk gene for Parkinson's disease

UTSW researchers uncover shape of key protein involved in muscle contraction

Where cancers spread can give specific insights on disease traits

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

Researchers discover how sweet taste perception is fine-tuned in response to diets

Recommendations for keeping cancer patients, providers safe during COVID-19 pandemic

Study sheds light on how a group of novel organelle-based disorders affects cells

Researchers identify COVID-19 drug lead treatments

Microneedle patches for potential COVID-19 vaccines or therapeutics

Weekly COVID-19 fatality predictions from leading epidemiologists

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Researchers identify protein that plays critical role in cancer treatment-related heart damage

‘Entry Point’ enzyme for COVID-19 higher in COPD patients and smokers

Researchers discover novel role for dopamine that impacts gene expression related to cocaine abuse

Improper cellular cleanup during neurodevelopment may cause lifelong behavioral issues

Join Our Cutting-edge Technical Program

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in